Angelini Ventures
Venture Capital And Private Equity Principals
Rome, IT
31 employees
STOCK
- Employees
- 31
- Contacts
- 4
- Emails
- 4
Angelini Ventures Overview
- Headquarters
- Rome, IT
- Website
- www.angeliniventures.com
- Industry
- Venture Capital And Private Equity Principals
- Employees
- 31
- Stock Symbol
- STOCK
- NAICS
-
Miscellaneous Intermediation
Keywords
About Angelini Ventures
Angelini Ventures is the venture capital arm of Angelini Industries funded with a €300 million capital commitment to build and invest in companies that develop innovative ideas and solutions in biotechnology, digital health and life sciences. Angelini Ventures invests across Europe and North America with a focus on brain health and consumer segments such as women, children and the elderly. The company is headquartered in Rome with a global team spread across Europe, Asia and the US to provide global perspective and capabilities.
Angelini Ventures Contact Details
- People in AeroLeads
- 4
- With contact data
- 4
- Email contacts
- 4
- 100.0% coverage
Angelini Ventures Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Mark Warne | United Kingdom |
Email
|
|
| Tanja Dowe | Managing Director, Angelini Ventures | Lausanne, Vaud, Switzerland |
Email
|
| Matthias Evers | Biopharma Exec, Advisor & Investor | Hamburg, Germany |
Email
|
| Thomas Michael Thestrup | Senior Principal @ Angelini Ventures | Copenhagen, Capital Region of Denmark, Denmark |
Email
|
Employees by Management Level
Director
1 profile
Senior / Lead
1 profile
Individual contributor
1 profile
Compare Similar Companies to Angelini Ventures
Angelini Pharma
Pharmaceutical Manufacturing
Angelini Industries
Manufacturing
Dutchie
Software Development
CDP Venture Capital SGR
Financial Services
Kurma Partners
Venture Capital And Private Equity Principals
Indaco Venture Partners
Venture Capital And Private Equity Principals
Panakes Partners
Venture Capital And Private Equity Principals
LVenture Group
Venture Capital And Private Equity Principals
Neumirna Therapeutics
Pharmaceutical Manufacturing
Claris Ventures
Venture Capital And Private Equity Principals